MF
Michael J. Farrell (Chief Executive Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in ResMed Inc. (RMD). The largest single filing was $1.4M of RMD (4,991 sh × $273.78, as filed), executed Feb 9. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.6M
shares × price, as filed
Last traded
Oct 7
Filed Oct 8
Median ADV $323.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $32.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
RMDRecent filings
RMDSALE
ResMed Inc.
View filing →
$2.0M8,009 sh × $251.21
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.9M
8,009 sh × $243.23
Exec May 7 2025
Filed May 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.7M
8,009 sh × $209.85
Exec Apr 7 2025
Filed Apr 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.8M
8,009 sh × $229.20
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.9M
8,009 sh × $236.77
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $499K
2,000 sh × $249.67
Exec Nov 27 2024
Filed Nov 27 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $3.6M
14,683 sh × $246.26
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET